Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TREATMENT OF SCHIZOPHRENIA - LETS TALK DOLLARS AND SENSE
Autore:
BUCKLEY PF;
Indirizzi:
CASE WESTERN RESERVE UNIV,NORTHCOAST BEHAV HEALTHCARE SYST,11100 EUCLID AVE CLEVELAND OH 44106 CASE WESTERN RESERVE UNIV,DEPT PSYCHIAT CLEVELAND OH 44106
Titolo Testata:
American journal of managed care
fascicolo: 3, volume: 4, anno: 1998,
pagine: 369 - 383
SICI:
1096-1860(1998)4:3<369:TOS-LT>2.0.ZU;2-R
Fonte:
ISI
Lingua:
ENG
Soggetto:
NEUROLEPTIC-RESISTANT SCHIZOPHRENIA; COST-EFFECTIVENESS; DRUG-THERAPY; HEALTH-CARE; ANTIPSYCHOTIC THERAPY; CLOZAPINE TREATMENT; RISPERIDONE; BENEFITS; PHARMACOECONOMICS; REDUCTION;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Physical, Chemical & Earth Sciences
Science Citation Index Expanded
Citazioni:
85
Recensione:
Indirizzi per estratti:
Citazione:
P.F. Buckley, "TREATMENT OF SCHIZOPHRENIA - LETS TALK DOLLARS AND SENSE", American journal of managed care, 4(3), 1998, pp. 369-383

Abstract

Schizophrenia is a major neurologic illness with an impact on public health that has been unappreciated. Newer and arguably move effective medication treatments are now available and hold considerable premise. The higher up-front cost of these drugs is, on current evidence, offset by other economic advantages and, from a humanitarian perspective, by the expectation of improved patient outcome with less drug toxicity. The extent to which these drugs replace older drug treatments will be determined by the relative influences of clinical, pharmacoeconomic,mental health administrative, and advocacy factors over the coming years.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 17:39:32